This is an open-label extension study intended for subjects who have previously completed
study A0221045 (fesoterodine in elderly OAB patients) and who have been recommended by the
investigator as being suitable for the extended use of Fesoterodine. Data from this study
will extend the evaluation of efficacy, tolerability and safety of Fesoterodine in older
subjects from Portugal.